PRINCETON, N.J. (CBSNewYork/AP) — Princeton University is about to administer the first doses of a vaccine against meningitis.
The Ivy League school has experienced an outbreak of type B meningococcal disease, which is sometimes life-threatening. Since March, seven Princeton students and one student visitor have been stricken by the bacterial illness.
University officials said the vaccine will be made available starting Monday and through Thursday, for nearly 6,000 people.
The Centers for Disease Control and Prevention has officially recommended all undergraduate students, graduate students living in dorms, the Graduate College and annexes, and employees with certain medical conditions receive the new vaccine.
Last month, the Food and Drug Administration, along with school officials, approved importing a vaccine not yet approved in the U.S. for limited use at the New Jersey campus. The vaccine, Bexsero, is approved for use in Europe and Australia.
Under state law, anyone living in dorm rooms must have vaccinations against other strains of meningitis. The vaccinations, however, do not cover type B.
Check Out These Other Stories From CBSNewYork.com:
- Shooting Near Battery Park Leaves 2 People Hospitalized
- Top UN Diplomats Invited To White House Luncheon Ahead Of Federal Budget Showdown
- Cause Of Deadly Queens House Fire Remains Unclear
- Elton John Calls Off Multiple U.S. Shows Due To Bacterial Infection
(TM and © Copyright 2013 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2013 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)